AQR Capital Management’s GeneDx Holdings WGS Stock Holding History

AQR Capital Management’s Portfolio WGS Stock Details WGS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.18M	Sell	18,390 -6,283	-25%	-$573K	﹤0.01%	2670
2025 Q4	$3.21M	Sell	24,673 -4,068	-14%	-$558K	﹤0.01%	1836
2025 Q3	$3.1M	Buy	28,741 +5,030	+21%	+$548K	﹤0.01%	1724
2025 Q2	$2.19M	Sell	23,711 -1,348	-5%	-$106K	﹤0.01%	1722
2025 Q1	$2.22M	Sell	25,059 -32,472	-56%	-$2.82M	﹤0.01%	1553
2024 Q4	$4.42M	Sell	57,531 -29,859	-34%	-$2.09M	0.01%	1156
2024 Q3	$3.71M	Buy	+87,390	New	+$2.95M	0.01%	1197
2023 Q3	–	Sell	-19,438	Closed	-$116K	–	2393
2023 Q2	$116K	Buy	+19,438	New	+$154K	﹤0.01%	2132
2022 Q4	–	Sell	-975	Closed	-$28K	–	2289
2022 Q3	$28K	Buy	975 +393	+68%	+$18K	﹤0.01%	2161
2022 Q2	$24K	Hold	582	–	–	﹤0.01%	2159
2022 Q1	$59K	Buy	+582	New	+$64.7K	﹤0.01%	2179

Other funds holding WGS

Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

ZDA

Zweig-DiMenna Associates New York $722M AUM 97.69% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

AQR Capital Management's WGS Position: Q1 2026 in Review

AQR Capital Management reduced its GeneDx Holdings (WGS) stake by 25% in Q1 2026, selling an estimated $573K and leaving 18,390 shares worth $1.18M. The position accounts for ﹤0.01% of the portfolio, ranked #2670.

AQR Capital Management first reported a position in WGS in Q1 2022 and has held it in 11 quarters since. The position peaked at $4.42M in Q4 2024. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

AQR Capital Management held 18,390 shares of GeneDx Holdings worth $1.18M as of Q1 2026.
AQR Capital Management sold 6,283 GeneDx Holdings shares in Q1 2026, an estimated $573K.
GeneDx Holdings made up ﹤0.01% of AQR Capital Management's portfolio in Q1 2026, its #2670 holding.
AQR Capital Management first reported a position in GeneDx Holdings in Q1 2022 and has held it in 11 quarters since.
AQR Capital Management's GeneDx Holdings position peaked at $4.42M in Q4 2024.
240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.